Disclosure of HIV Status

Disclosing your HIV status means telling someone — a partner, a clinician, or another person who needs to know — that you live with HIV. It matters most before sex or sharing injection equipment, but with consistent treatment and an undetectable viral load you do not transmit HIV to sex partners. The how, when, and to whom is part medical, part personal, and part legal.

What disclosure of HIV status actually means

Disclosure is the act of sharing that you have HIV with another person. There are three audiences. The first is your own care team — doctors, nurses, dentists — who need accurate history to treat you safely. The second is sexual or needle-sharing partners, where disclosure connects to transmission risk and, in many states, to the law. The third is everyone else: family, friends, employers, who have no medical claim on the information at all. Each of these is a separate decision, and you control most of them.

HIV is a virus that attacks the immune system CDC. It moves through three stages — an acute phase with very high viral load, a long chronic phase that can run a decade or more untreated, and AIDS, the most advanced stage. If the distinction between the two terms is unclear, here's a plain breakdown of aids vs hiv. HIV is a manageable, long-term condition, and disclosure is about safety and honesty.

Symptoms — and the silent reality

You often can't tell who has HIV from how they look or feel. Within two to four weeks of infection, many people get a flu-like illness called acute retroviral syndrome — fever, chills, rash, night sweats, muscle aches, sore throat, fatigue, swollen lymph nodes, mouth ulcers hiv.gov. About 90% of newly infected people get some of these symptoms, and they peak when the viral load is highest and the virus is most contagious.

These symptoms look identical to the flu, and some people get none at all. A test is the only thing that can confirm or rule out HIV. After the acute phase comes clinical latency, often years with no symptoms while the virus stays active. Someone can feel completely well and still transmit HIV if they don't know their status and aren't on treatment. "I feel fine" is never a substitute for a test result when you're deciding what to tell a partner.

How HIV spreads — what you're actually disclosing about

Understanding transmission keeps disclosure grounded in fact. Only certain body fluids carry enough HIV to infect: blood, semen, vaginal fluid, rectal fluid, and breast milk CDC. The routes that matter are anal or vaginal sex, sharing needles or other injection equipment, and from parent to child during pregnancy, birth, or breastfeeding.

Saliva and kissing don't transmit HIV. Neither does casual contact, sharing food or utensils, toilet seats, surfaces, insect bites, water, air, or donating blood, because the virus doesn't survive long outside the body. So disclosure isn't owed to a coworker, a friend you hug, or someone you share a meal with. It's relevant to people with whom you have a real fluid-exposure risk. Knowing this lets you draw a sane boundary around who needs the information.

How HIV is tested

Disclosure starts with knowing your status, and that means a test. Options range from a finger-stick or oral-swab rapid test that returns results in minutes to a lab blood draw CDC. Testing is free at many health departments, and at-home kits exist. Watch the window period, the time after exposure before a test turns reliably positive.

Window periods vary by test type. A nucleic-acid test (NAT) can detect HIV roughly 10–33 days after exposure; a fourth-generation antigen/antibody lab test, about 18–45 days; and antibody or rapid tests, about 23–90 days. A negative result is conclusive only after the window has passed with no exposure during it. If you're timing a test around a specific risk, read when to test after exposure before you trust a result. USPSTF gives HIV screening a Grade A recommendation — everyone ages 15 to 65 should test at least once, and people at higher risk should repeat at least annually USPSTF. Here's how to get tested, and you can compare testing providers to find one that fits.

Treatment — and why U=U changes the disclosure conversation

Everyone diagnosed with HIV should start antiretroviral therapy (ART) as soon as possible CDC. ART is a combination of medicines — often a single daily pill — drawn from classes including integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors. It's lifelong, and the goal is an undetectable viral load. There's no cure, but treatment turns HIV into a controllable condition. A young adult who starts ART before their CD4 count drops below 200 now has a life expectancy approaching the general population's.

The single most important fact for disclosure is U=U: undetectable equals untransmittable. A person on ART who stays virally suppressed will not transmit HIV to sex partners CDC. Across the PARTNER, Opposites Attract, and PARTNER2 studies, mixed-status couples had more than 125,000 condomless sex acts and recorded zero linked transmissions while the partner with HIV was undetectable Lancet. Most people reach undetectable within six months of starting treatment. Treatment is both your health plan and your prevention plan, and starting earlier hiv treatment can help prevention for everyone around you.

Complications if HIV goes untreated

Untreated HIV slowly destroys the immune system and progresses to AIDS — defined by a CD4 count under 200 cells/mm³ or an opportunistic infection StatPearls. Opportunistic infections are illnesses a healthy immune system normally fends off — certain pneumonias, fungal infections, and cancers — that take hold once defenses collapse. The disclosure conversation isn't only about protecting partners; it's about getting yourself into care. The same diagnosis that prompts disclosure opens the door to treatment that prevents this trajectory.

Prevention — the full toolkit

Disclosure works alongside a set of prevention tools, and an HIV-negative partner you disclose to has real options. The CDC's core tools are condoms, PrEP, PEP, treatment-as-prevention (U=U), and regular testing CDC.

PrEP is pre-exposure prophylaxis for people without HIV who are exposed through sex or injection drug use. Taken as prescribed, it reduces sexual HIV risk by about 99% and injection-related risk by at least 74%. Options include daily Truvada and Descovy and the long-acting injectable cabotegravir (Apretude). Descovy isn't approved for people at risk through receptive vaginal sex or for those who inject drugs, while Truvada is approved for all those routes. PrEP requires a confirmed negative HIV test before starting and at follow-up visits, because starting with undiagnosed HIV risks drug resistance. A twice-yearly injectable, lenacapavir, produced zero infections among women in the PURPOSE 1 trial WHO.

PEP is post-exposure prophylaxis — emergency medicine for someone who may have just been exposed. It's a 28-day course that must start within 72 hours, and it cut HIV seroconversion by about 81% in the original study CDC. If a disclosure conversation reveals a recent possible exposure, pep for hiv is a same-day emergency — an urgent-care or ER visit, not a future test appointment.

If you're pregnant and living with HIV, disclosure to your obstetric team is critical because perinatal transmission is largely preventable. With ART during pregnancy and labor plus newborn prophylaxis, the risk of passing HIV to a baby can drop to less than 1%.

When to see a clinician

See a clinician for an HIV test if you've had a possible exposure, develop flu-like symptoms after a risk, or simply haven't been screened — everyone should test at least once. Acute HIV is when the viral load is highest and the virus most contagious, so flu-like symptoms after a risk warrant an urgent test rather than a guess. If a possible exposure happened within the last three days, skip the wait and go to urgent care or an ER about PEP today. And if you test positive, the first appointment matters: starting treatment promptly protects your health and, through U=U, your partners.